Chapters

Transcript

Video

Next Questions: Chronic Lymphocytic Leukemia

Jennifer Brown, MD, PhD, shares about multiple treatments and drug therapies and how long patients can remain on them while determining the best outcomes.


Published

March 10, 2021

Created by

Dana-Farber

Related Presenters

Jennifer R. Brown, MD, PhD

Jennifer R. Brown, MD, PhD

Medical Oncology

Jennifer R. Brown, MD, PhD is the Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School in Boston, Massachusetts.

View Full Profile